Exosomes are particles that release naturally from a cell. These particles are responsible for cell to cell communication. These messenger cells have the ability to release growth factors and other beneficial processes.
February 12, 2020
Feb 12, 2020
Medical Director | DVC Stem
Exosome therapy is gaining popularity in the field of regenerative medicine. So what are exosomes? Are they a viable treatment option? How are exosomes related to stem cells?
Exosomes are extracellular vesicles (particles that release naturally from a cell that cannot replicate) that are responsible for cell to cell communication. Exosomes are released naturally from cells upon the fusion of a discontinuous closed membrane system, also known as the intermediate endocytic compartment. Although exosomes are roughly the same size (40-100 nm) as ectosomes, they are different species of vesicles.
Exosome therapy is gaining in popularity within the United States. Some doctors believe there may be benefits with the administration of exosomes, but there is minimal data proving safety and efficacy. This theory may have originated from studies that suggest the link between the health benefits of mesenchymal stem cells and exosomes. Exosomes are released naturally from mesenchymal stem cells, and MSCs have the highest amount of exosomes out of any cell. These studies (outlined below) argue that exosomes may have therapeutic abilities, but researchers have found no conclusive evidence. There is also a regulatory concern about the legality of such treatments, especially when the exosome preparation protocol involves extraction from MSCs.
According to James R Edgar,
“This could be due to three reasons. Firstly, exosomes are thought to provide a means of intercellular communication and transmission of macromolecules between cells. Second, in the past decade, exosomes have been attributed roles in the spread of proteins, lipids, mRNA, miRNA, and DNA and as contributing factors in the development of several diseases. Thirdly, exosomes have been proposed to be useful vectors for drugs because they are composed of cell membranes rather than synthetic polymers, and as such, could be better tolerated by the host.” (1)
Mesenchymal stem cells (MSCs) can self-renew and can be isolated from various tissues. They have been tested widely in clinical trials due to their multitude of biological functions, including; differentiation, tissue repair, anti-inflammatory, and immunomodulatory properties.
Exosomes derived from mesenchymal stem cells (MSCs), first investigated in a 2010 finding, showed that MSCs were able to produce higher amounts of exosomes than other cells. (2)
According to Zhang, exosomes are involved in cell to cell communication, and some researchers hypothesize that they are the paracrine effectors of MSCs.
Many types of cells secrete exosomes, including T and B cells, cancer cells, and stem cells. Although Exosomes are essential for cellular communication, their functions remain unknown.
Mesenchymal stem cells may have the ability to repair tissue, modulate the immune system, and promote an anti-inflammatory response in patients. In an article published in the International Journal of Molecular Sciences, Zhang et al. state that “Several studies have reported that exosomes have functions similar to MSCs; however, the mechanisms are still not fully understood and remain controversial.” (2)
“Given the merits of MSCs, exosomes hold great promise as a controllable, manageable, and feasible approach in future studies. However, based on the proteomic and genomic complexities of exosomes, their possible mechanisms and exact compositions need further investigation.”
Mesenchymal stem cells can produce prolific amounts of exosomes. Exosomes derived from mesenchymal stem cells have the potential to be used as a vehicle for drug or gene delivery or to facilitate cell therapy. (2) The study concluded that exosomes hold promise, but more studies are required before being able to consider using exosomes alone as a potential treatment option.
Clinics in the United States are hailing exosome therapy for anti-aging as a new miracle cure. Some of these entities state that exosomes are more potent than MSCs at combating certain conditions. There are a few issues with these claims; firstly, there is a lack of data supporting the efficacy of exosomes without also introducing MSCs into the patient. Secondly, there are regulation concerns with exosomes in the United States that may promote the use of exosomes as a way of offering cell therapy while avoiding legal limitations set forth from the FDA. While there could potentially be some benefits with exosomes, they are still mostly understudied and unknown.
Treatment with expanded MSCs is primarily not authorized by the FDA in the United States. These cells require approval from the FDA and require an Investigational New Drug Application (IND) submission. These regulations directly correlate with the rise in the popularity of exosome therapies. The regulatory environment in the United States and the disparity between different therapeutics can benefit clinics that market and administer exosomes because it may be easier to bypass the 4th criterion of 361 HCT/P’ S.
Exosome therapy may eventually have a place in the regenerative medicine sphere, but for now, it seems as though the development of using exosomes for treatment is still in its early stages. It is vital to have reliable data from clinical studies in human subjects that can prove that these exosome products functionally work.
DVC Stem is a stem cell therapy pioneer, offering stem cell therapies for years and has become a cornerstone of the medical tourism industry. Located in the tropical paradise of Grand Cayman in the Western Caribbean, we offer patients a nearby alternative to traveling long distances and to less ideal locations. Our protocols are IRB approved, and our cells come from regulated, U.S. based, FDA compliant laboratories. We seek to offer the highest quality products, the latest available treatments for a variety of conditions, all combined with a world-class setting and service. We offer treatment that includes the intravenous administration of over 300 million cord tissue-derived mesenchymal stem cells.
About the author
Dr. Cona has been performing stem cell therapy for over 10 years. He is a member of the World Academy of Anti-Aging Medicine (WAAAM). He is also a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians. He is the Medical Director for DVC Stem a world-renowned stem cell therapy clinic located in Grand Cayman.
Are you a candidate for stem cell treatment?
Complete our brief online application to find out if our IRB-approved mesenchymal stem cell treatment is right for you.Apply for treatment
You might also like...
The borders of the Cayman Islands are in a phased reopening process, which will expand within the next couple of months. This means that the airport is open but travel must be approved by the Cayman Islands Government & all visitors must participate in a mandatory 10 - 14 day quarantine.
Stem cell therapy results have been extremely positive so far, with approximately 75% of Multiple Sclerosis patients reporting significant improvement within 3 months of treatment, and showing little to no signs of regression out to 18-24 months. Our full Multiple Sclerosis study results are expected to be published later this year.
New study has found mesenchymal stem cells to be both a safe and effective treatment option for stroke.
Are people with Multiple Sclerosis more prone to severe Coronavirus related illness? Having a compromised immune system could potentially increase one’s risk of developing severe Coronavirus symptoms. This article aims to answer this question as well as describe the actions MS patients should take to mitigate risk.
Explaining the relationship between stem cell therapy and Parkinson's.
DVC STEM, GRAND CAYMAN